Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapyW Demark-Wahnefried, B L Peterson, E P Winer, et al.
Annals of Surgical Oncology|October 1, 2010
Does neoadjuvant bevacizumab increase surgical complications in breast surgery?M Golshan, J E Garber, R Gelman, et al.
Journal of the National Cancer Institute|September 1, 1993
Silicone controversy: a survey of women with breast cancer and silicone implantsE P Winer, K Fee-Fulkerson, C C Fulkerson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2021
Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021H J Burstein, G Curigliano, B Thürlimann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 7, 2012
Persistence, adherence, and toxicity with oral CMF in older women with early-stage breast cancer (Adherence Companion Study 60104 for CALGB 49907)K J Ruddy, B N Pitcher, L E Archer, et al.
Breast Cancer Research and Treatment|May 9, 2018
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancerM L Telli, D G Stover, S Loi, et al.
Oncogene|October 27, 2015
PI3K-p110α mediates resistance to HER2-targeted therapy in HER2+, PTEN-deficient breast cancersQ Wang, P Liu, J M Spangle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 6, 2013
A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancerS M Tolaney, J Najita, J Sperinde, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancerK A Havlin, M J Ramirez, C M Legler, et al.
Cancer Research|May 1, 1992
Modulation of O6-alkylguanine-DNA alkyltransferase-mediated carmustine resistance using streptozotocin: a phase I trialT J Panella, D C Smith, S C Schold, et al.
Pageof 9